DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
Coverage details, prior authorization criteria, copay ranges, and appeal strategy for 2026. Verified May 1, 2026.
Integrated payer-provider — Kaiser physician must prescribe through Kaiser pharmacy. PA criteria are clinical-judgment-driven by the prescribing Kaiser provider, not external utilization mgmt. Easier path if you have a sympathetic Kaiser PCP.
Kaiser Permanente requires the following before approving Saxenda:
Top denial patterns we see in 2026 based on appeal-claim data:
Pediatric Saxenda (12-17) is straightforward through Kaiser pediatric endocrinology. Adult: Wegovy is preferred — Saxenda used only with daily-injection preference or Wegovy intolerance.
Kaiser member services → Grievance & Appeals → discuss directly with prescribing physician first.
Saxenda (liraglutide 3mg) carries the following FDA-approved indications. Off-label use is the #1 PA denial reason — ensure your prescribing diagnosis matches one of these.
Coverage details verified May 1, 2026 against Kaiser Permanente formulary documentation. Formulary changes happen quarterly — always verify against your specific plan before prescribing.